SPC182
Levófloxasín, einkum lausn af levófloxasíni og tvígildri eða þrígildri katjón, valkvætt magnesín katjón, til dæmis lausn af levófloxasíni og magnesínklóríð
Status:
HafnaðApplication date:
1.2.2017Application published:
15.3.2017
Max expiry date:
29.3.2030Next due date:
31.5.2026Medicine name:
QuinsairMedicine for children:
No
Timeline
Today
1.2.2017Application
15.3.2017Publication
29.3.2030Expires
Marketing license
IS authorization number:
EU/1/14/973/001Date:
19.4.2015
Foreign authorization number:
EU/1/14/973Date:
26.3.2015
Owner
Name:
Horizon Therapeutics U.S. Holding LLCAddress:
1 Horizon Way,, Deerfield, Illinois 60015 US
Agent
Name:
Ólafur Ragnarsson hrl., PaticeAddress:
Pósthólf 8236, 128 Reykjavík
Patent
Number:
EP1901749